Genetic syndromes that increase the risk of childhood cancers provide essential insights into the genetic mechanisms that drive tumor formation. Syndromes like Li-Fraumeni, neurofibromatosis, and retinoblastoma are associated with a higher incidence of pediatric cancers due to inherited mutations that affect tumor suppressor genes or DNA repair mechanisms. Studying these conditions helps researchers better understand the genetic mutations that predispose children to cancers, allowing for earlier detection and intervention strategies. Furthermore, identifying the genetic basis of these syndromes aids in the development of targeted treatments tailored to the specific molecular characteristics of each condition, offering potential for more effective and personalized therapies for pediatric cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States